Koyfin Home > Directory > Health Care > Acadia Pharmaceutica > EV / EBITDA (ltm)

Acadia Pharmaceutica EV / EBITDA (ltm) Chart (ACAD)

Acadia Pharmaceutica annual/quarterly EV / EBITDA (ltm) from 2010 to 2012. Enterprise multiple, also known as the EBITDA multiple, is a ratio used to determine the value of a company. It uses the consensus estimate EBITA over the last twelve months (LTM). The enterprise multiple looks at a firm in the way a potential acquirer might by considering the company's debt, which other multiples such as P/E do not include.
  • Acadia Pharmaceutica EV / EBITDA (ltm) for the quarter ending March 03, 2012 was 3.84 a -12.56% decrease of -0.48 year over year
  • Acadia Pharmaceutica EV / EBITDA (ltm) for the last 12 months ending March 03, 2012 was 3.84 a -12.56% decrease of -0.48 year over year
  • Acadia Pharmaceutica Annual EV / EBITDA (ltm) for 2012 was 3.84 a -3.42% decrease of -0.13 from 2011
  • Acadia Pharmaceutica Annual EV / EBITDA (ltm) for 2012 was 3.97 a -6.62% decrease of -0.26 from 2011
  • Acadia Pharmaceutica Annual EV / EBITDA (ltm) for 2012 was 4.24 a -2.07% decrease of -0.09 from 2011
Other Valuation Metrics:
  • Acadia Pharmaceutica Market Cap for the quarter ending March 03, 2018 was $2,802m a -21.48% decrease of -602m year over year
  • Acadia Pharmaceutica Price / Book for the quarter ending March 03, 2018 was 8.34 a 10.81% increase of 0.90 year over year
  • Acadia Pharmaceutica Enterprise Value for the quarter ending March 03, 2018 was $2,461m a -19.25% decrease of -474m year over year
View Chart On Koyfin

Quarterly ACAD EV / EBITDA (ltm) Data

03/20123.84
03/20123.97
03/20124.24
02/20124.32
02/20124.46
02/20124.72
02/20124.72
02/20124.59
02/20124.24
02/20124.54

Annual ACAD EV / EBITDA (ltm) Data

20123.84
20123.97
20124.24
20124.32
20124.46
20124.72
20124.72
20124.59
20124.24
20124.54